Program｜The 40th Annual Meeting of the Japan Society for Hematopoietic Cell Transplantation

* For the full program, Please find more here. *Japanese only

Friday, February 2, 2018, 13:00-14:30


Chairs	：	Shinichiro Okamoto (Division of Hematology, Department of Internal Medicine, Keio University School of Medicine)
		Takanori Teshima (Department of Hematology, Hokkaido University Faculty of Medicine)
Presenters	：	Challenge the Current Paradigm of Graft-vs.-Host Disease Takanori Teshima (Department of Hematology, Hokkaido University Faculty of Medicine)
		Mechanisms of Leukemia Immune Evasion and Relapse after Allogeneic HSCT Luca Vago (Hematology and Bone Marrow Transplantation Unit, IRCCS San Raffaele Scientific Institute Milano, Italy)
		Stem Cell Transplant in 2018 and Beyond Richard J. Jones (Bone Marrow Transplant Program, Hematologic Malignancies Program, Oncology and Medicine, Johns Hopkins University, U.S.A.)

Saturday, February 3, 2018, 9:30-11:10


Chairs	：	Shinichiro Okamoto (Division of Hematology, Department of Internal Medicine. Keio University School of Medicine)
		Jong-Ho Won (Department of Oncology and Hematology, Soon Chun Hyang University Hospital, Seoul, Korea)
Presenters	：	New strategy using cellular therapy to enhance early hematopoietic/ immunological recovery after cord blood transplant in Japan Satoshi Takahashi (Division of Molecular Therapy The Institute of Medical Science, The University of Tokyo)
		Recent Progress of HSCT from Haplotype Mismatched Donors in Adult Patients with AML Hee-Je Kim (The Catholic University of Korea, Korea)
		Ex vivo αβ T cell-depleted haploidentical hematopoietic cell transplantation and cellular therapy post-transplantation Ho Joon Im (Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Korea)
		The current status of HLA haplo-identical transplantation using posttransplantation high-dose cyclophosphamide （PT/Cy） Hirohisa Nakamae (Hematology, Graduate School of Medicine, Osaka City University)

Friday, February 2, 2018, 14:40-15:55


Chairs	：	Hirokazu Murakami (Gunma University Graduate School of Health Sciences)
		Kosei Matsue (Department of Hematology and Oncology, Kameda Medical Center)
Presenters	：	Autotransplant （tentative） Philippe Moreau (Department of Hematology, University Hospital Nantes, France)
		Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma Sergio A. Giralt (Memorial Sloan Kettering Cancer Center, U.S.A.)
		How I treat Myeloma and Related Disorders with Transplant: Uncommon Plasma Cell Disorders Shaji Kumar (Mayo Clinic, Rochester, Minnesota, U.S.A.)

Friday, February 2, 2018, 9:00-11:00


Chairs	：	Koichi Akashi (Department of Medicine and Biosystemic Science, Faculty of Medicine, Kyushu University)
		Yoshiyuki Takahashi (Department of Pediatrics, Developmental Pediatrics, Nagoya University Graduate School of Medicine)
Presenters	：	The role of immunotherapy in patients with adult T-cell leukemia/lymphoma Koji Kato (Department of Hematology, Oncology and Cardiovascular medicine, Kyushu University Hospital, Fukuoka, Japan)
		Pharmacologic agents to prevent and treat relapse after allogeneic transplantation Robert J. Soiffer (Dana-Faber Cancer Institute, U.S.A.)
		Allogeneic CD19-CAR-T cell infusion after allogeneic hematopoietic stem cell transplantation in B cell acute lymphoblastic leukaemia Kaiyan Liu (Institute of Hematology, Peking University, China)
		Cord blood transplantation and cellular therapy Elizabeth J. Shpall (MD Anderson Cancer Center, U.S.A.)

Saturday, February 3, 2018, 9:00-11:00


Chairs	：	Junji Tanaka (Department of Hematology, Tokyo Women's Medical University)
		Yoshinobu Maeda (Department of Hematology, Oncology, Allergy and Respiratory Medicine, Okayama University)
Presenters	：	NKT and Tolerance, Revisited; Liposomal α-GalCer as an Immune Modulator after Reduced-Dose PTCy Ken-ichi Matsuoka (Department of Hematology and Oncology, Okayama University)
		Posttransplant immune-mediated hematopoietic failure: A common cause of late graft failure in patients with complete donor chimerism Shinji Nakao (Kanazawa University Hematology/Respiratory Medicine)
		The role of the intestinal microbiome in allo HCT Marcel RM van den Brink (Memorial Sloan Kettering Cancer Center, U.S.A.)
		Impact of genetic alterations on transplant outcomes for MDS Yasuhito Nannya (Department of Pathology and Tumor Biology, Kyoto University, Japan)

Saturday, February 3, 2018, 13:00-14:40


Chairs	：	Hideo Harigae (Department of Hematology and Rheumatology, Tohoku University School of Medicine)
		Hiroyasu Ogawa (Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine)
Presenters	：	Autotransplant for HL in the era of novel therapy Robert W. Chen (City of Hope Hospital Duarte, Comprehensive Cancer Center, U.S.A.)
		Autotransplant in the Era of Novel Agents in Myeloma Meletios A. Dimopoulos (University Athens School of Medicine, Greece)
		Myeloablative and reduced-intensity conditioning in HLA –haploidentical peripheral blood stem cell transplantation using posttransplant cyclophosphamide Junichi Sugita (Department of Hematology, Hokkaido University Faculty of Medicine)
		MRD oriented therapy in adult acute lymphoblastic leukemia Koji Nagafuji (Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine)

Program